Treace Medical Concepts, Inc. (TMCI)
Designs surgical devices that correct bunion and foot deformities through minimally invasive procedures.
$4.01-0.02%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-24.9%
The outlook
TMCI trades at $4.01, positioned in the lower half of its 52-week range but above both its 50- and 200-day moving averages. Analyst coverage is thin with a "Hold" consensus, though the average price target sits roughly 16% above the current price. The stock leans bullish overall according to its technical positioning.
What’s behind the score
Analyst consensusHold — 2.8 avg of 3 analysts
Price trendAbove its 50- & 200-day averages
52-week range43% of the way from its 52-week low to high
Price targetAvg target +16% vs current price
Analyst price target
~12-month · 3 analysts$4.67average target+16.4% vs now
Now $4.01
Low $3.00High $7.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$260.1M
52-wk high
$7.78
52-wk low
$1.17
50-day avg
$3.84
200-day avg
$3.08
Trailing P/E
—